AU2001274446A1 - Vip-related peptides for the treatment of skin disorders - Google Patents

Vip-related peptides for the treatment of skin disorders

Info

Publication number
AU2001274446A1
AU2001274446A1 AU2001274446A AU7444601A AU2001274446A1 AU 2001274446 A1 AU2001274446 A1 AU 2001274446A1 AU 2001274446 A AU2001274446 A AU 2001274446A AU 7444601 A AU7444601 A AU 7444601A AU 2001274446 A1 AU2001274446 A1 AU 2001274446A1
Authority
AU
Australia
Prior art keywords
vip
treatment
skin disorders
related peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274446A
Inventor
E. Douglas Brenneman
Matityahu Fridkin
Illana Gozes
Ruth Granoth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Yeda Research and Development Co Ltd
US Department of Health and Human Services
Original Assignee
Ramot at Tel Aviv University Ltd
Yeda Research and Development Co Ltd
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd, Yeda Research and Development Co Ltd, US Department of Health and Human Services filed Critical Ramot at Tel Aviv University Ltd
Publication of AU2001274446A1 publication Critical patent/AU2001274446A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
AU2001274446A 2000-06-07 2001-06-07 Vip-related peptides for the treatment of skin disorders Abandoned AU2001274446A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13663100A IL136631A0 (en) 2000-06-07 2000-06-07 Vip-related peptides for treatment of skin disordes
IL136631 2000-06-07
PCT/IL2001/000523 WO2001093889A2 (en) 2000-06-07 2001-06-07 Vip-related peptides for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
AU2001274446A1 true AU2001274446A1 (en) 2001-12-17

Family

ID=11074239

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274446A Abandoned AU2001274446A1 (en) 2000-06-07 2001-06-07 Vip-related peptides for the treatment of skin disorders

Country Status (4)

Country Link
EP (1) EP1307217A2 (en)
AU (1) AU2001274446A1 (en)
IL (1) IL136631A0 (en)
WO (1) WO2001093889A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2730615A1 (en) * 2008-07-18 2010-01-21 Galderma Research & Development Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them
US9669092B2 (en) * 2011-02-02 2017-06-06 Emory University Antagonism of the VIP signaling pathway

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2001093889A3 (en) 2003-02-27
WO2001093889A2 (en) 2001-12-13
EP1307217A2 (en) 2003-05-07
IL136631A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2003286567A1 (en) Methods for the treatment of skin disorders
WO2003033720A8 (en) Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AUPR074500A0 (en) Treatment of t cell disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002319286A1 (en) Skin treatment
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU7106300A (en) Treatment of skin disorders
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU3899100A (en) Treatment of hyperactivity disorders
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders
AU1405001A (en) Treatment of diseases
AU2683500A (en) Compositions for the treatment of pain
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
AU2002312779A1 (en) Delta-aminolevulinic acid for the therapeutical and cosmetic use
AU2002365654A1 (en) Treatment of diseases via the skin
AU3582101A (en) The treatment of functional gastrointestinal disorders
AU5759500A (en) Methods for ameliorating icthyosiform skin diseases
AUPQ902000A0 (en) Pharmaceutical composition for the treatment of skin conditions
AU2001290553A1 (en) Method for using activated protein c for the treatment of coagulation-associated disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 55733/00, 66815/00, 69831/00, 65707/01, 65708/01, 66125/01, 66342/01, 67132/01, 67134/01, 67140/01, 67141/01, 67143/01, 67144/01, 67145/01, 67147/01, 67154/01, 67697/01, 68950/01, 69171/01, 69227/01, 69246/01, 70676/01, 70683/01, 72357/01, 74142/01, 74446/01, 74630/01, 74652/01, 76273/01, 76284/01, 77465/01